Some of the isatin-derived compounds of type 173 exhibited inhibitory properties toward acetylcholinesterase that could be useful for Alzheimer’s disease therapy (Scheme 58) [90]. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.